Profarma Distribuidora de Produtos Farmacêuticos S.A. (PFRM3.SA)
BRL 7.45
(0.95%)
BRL 7.45
(0.95%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.39 Billion BRL | 19.08% |
| 2022 | 2.85 Billion BRL | 11.63% |
| 2021 | 2.55 Billion BRL | 9.94% |
| 2020 | 2.32 Billion BRL | 6.75% |
| 2019 | 2.17 Billion BRL | 16.57% |
| 2018 | 1.86 Billion BRL | -0.24% |
| 2017 | 1.87 Billion BRL | -4.08% |
| 2016 | 1.95 Billion BRL | 21.0% |
| 2015 | 1.61 Billion BRL | 41.68% |
| 2014 | 1.13 Billion BRL | -5.61% |
| 2013 | 1.2 Billion BRL | 40.41% |
| 2012 | 859.67 Million BRL | 27.77% |
| 2011 | 672.81 Million BRL | 21.96% |
| 2010 | 551.68 Million BRL | 18.41% |
| 2009 | 465.91 Million BRL | 3.99% |
| 2008 | 448.04 Million BRL | -6.81% |
| 2007 | 480.76 Million BRL | 29.21% |
| 2006 | 372.08 Million BRL | 6.09% |
| 2005 | 350.73 Million BRL | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.71 Billion BRL | 9.27% |
| 2024 Q2 | 3.36 Billion BRL | -9.48% |
| 2024 Q3 | 3.49 Billion BRL | 3.94% |
| 2023 Q1 | 3.29 Billion BRL | 15.38% |
| 2023 Q2 | 3.09 Billion BRL | -5.9% |
| 2023 Q3 | 3.13 Billion BRL | 1.08% |
| 2023 Q4 | 3.39 Billion BRL | 8.51% |
| 2023 FY | 3.39 Billion BRL | 19.08% |
| 2022 Q1 | 3.05 Billion BRL | 19.66% |
| 2022 Q2 | 2.78 Billion BRL | -8.94% |
| 2022 Q3 | 2.65 Billion BRL | -4.75% |
| 2022 Q4 | 2.85 Billion BRL | 7.56% |
| 2022 FY | 2.85 Billion BRL | 11.63% |
| 2021 Q4 | 2.55 Billion BRL | 9.05% |
| 2021 Q1 | 2.68 Billion BRL | 15.38% |
| 2021 FY | 2.55 Billion BRL | 9.94% |
| 2021 Q2 | 2.47 Billion BRL | -7.88% |
| 2021 Q3 | 2.34 Billion BRL | -5.15% |
| 2020 Q4 | 2.32 Billion BRL | 2.09% |
| 2020 Q1 | 2.58 Billion BRL | 18.43% |
| 2020 FY | 2.32 Billion BRL | 6.75% |
| 2020 Q3 | 2.27 Billion BRL | -4.99% |
| 2020 Q2 | 2.39 Billion BRL | -7.07% |
| 2019 Q3 | 2.16 Billion BRL | 4.78% |
| 2019 Q1 | 2.03 Billion BRL | 8.64% |
| 2019 Q4 | 2.17 Billion BRL | 0.62% |
| 2019 Q2 | 2.06 Billion BRL | 1.77% |
| 2019 FY | 2.17 Billion BRL | 16.57% |
| 2018 FY | 1.86 Billion BRL | -0.24% |
| 2018 Q1 | 1.64 Billion BRL | -12.04% |
| 2018 Q4 | 1.86 Billion BRL | 10.45% |
| 2018 Q3 | 1.69 Billion BRL | 0.98% |
| 2018 Q2 | 1.67 Billion BRL | 1.69% |
| 2017 Q4 | 1.87 Billion BRL | 0.48% |
| 2017 Q3 | 1.86 Billion BRL | -6.78% |
| 2017 Q2 | 2 Billion BRL | -1.18% |
| 2017 Q1 | 2.02 Billion BRL | 3.62% |
| 2017 FY | 1.87 Billion BRL | -4.08% |
| 2016 Q2 | 1.52 Billion BRL | -7.46% |
| 2016 FY | 1.95 Billion BRL | 21.0% |
| 2016 Q1 | 1.64 Billion BRL | 2.09% |
| 2016 Q3 | 1.45 Billion BRL | -4.37% |
| 2016 Q4 | 1.95 Billion BRL | 33.93% |
| 2015 FY | 1.61 Billion BRL | 41.68% |
| 2015 Q1 | 1.32 Billion BRL | 15.96% |
| 2015 Q2 | 1.18 Billion BRL | -10.15% |
| 2015 Q4 | 1.61 Billion BRL | 22.77% |
| 2015 Q3 | 1.31 Billion BRL | 10.75% |
| 2014 Q4 | 1.13 Billion BRL | 7.78% |
| 2014 FY | 1.13 Billion BRL | -5.61% |
| 2014 Q2 | 1.11 Billion BRL | -5.28% |
| 2014 Q1 | 1.17 Billion BRL | -2.66% |
| 2014 Q3 | 1.05 Billion BRL | -5.02% |
| 2013 Q2 | 1.06 Billion BRL | 2.48% |
| 2013 Q3 | 1.16 Billion BRL | 9.75% |
| 2013 Q4 | 1.2 Billion BRL | 3.32% |
| 2013 FY | 1.2 Billion BRL | 40.41% |
| 2013 Q1 | 1.03 Billion BRL | 20.83% |
| 2012 Q4 | 859.67 Million BRL | 37.65% |
| 2012 FY | 859.67 Million BRL | 27.77% |
| 2012 Q3 | 624.54 Million BRL | -3.37% |
| 2012 Q1 | 726.76 Million BRL | 8.02% |
| 2012 Q2 | 646.35 Million BRL | -11.06% |
| 2011 Q3 | 445.14 Million BRL | -5.86% |
| 2011 Q1 | 571.33 Million BRL | 3.56% |
| 2011 FY | 672.81 Million BRL | 21.96% |
| 2011 Q2 | 472.83 Million BRL | -17.24% |
| 2011 Q4 | 672.81 Million BRL | 51.15% |
| 2010 Q4 | 551.68 Million BRL | 0.0% |
| 2010 Q2 | 356.6 Million BRL | -29.26% |
| 2010 FY | 551.68 Million BRL | 18.41% |
| 2010 Q1 | 504.11 Million BRL | 8.2% |
| 2009 FY | 465.91 Million BRL | 3.99% |
| 2009 Q4 | 465.91 Million BRL | 24.44% |
| 2009 Q3 | 374.4 Million BRL | 0.0% |
| 2008 Q4 | 448.04 Million BRL | 0.0% |
| 2008 FY | 448.04 Million BRL | -6.81% |
| 2007 FY | 480.76 Million BRL | 29.21% |
| 2006 FY | 372.08 Million BRL | 6.09% |
| 2005 FY | 350.73 Million BRL | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|